|
|
|
|
||
Incyte is the first designated All starI have talked about this designation several times on the biotech board. These are companies that meet all the following criteria. 1. gets 4 out of 5 stars in the fundamental analysis 2. has breakthrough therapy designation for at leas one indication 3. has 80% institutional ownership or higher 4. is owned by the Baker Brothers Incyte meets and exceeds all these criteria at 4.32 stars, BTD for Graft vs Host Disease, 95% institutional ownership, and is the largest position owned by the Baker Brothers. |
return to message board, top of board |